References
- Huppert JL . Four-stranded nucleic acids: structure, function and targeting of G-quadruplexes. Chem. Soc. Rev.37, 1375–1384 (2008).
- Burge S , ParkinsonGN, HazelP, ToddAK, NeidleS. Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res.34, 5402–5415 (2006).
- Neidle S . Therapeutic Applications of Quadruplex Nucleic Acids. Academic Press, Oxford, UK (2011).
- Biffi G , TannahillD, McCaffertyJ, BalasubramanianS. Quantitative visualization of DNA-G-quadruplex structures in human cells. Nat. Chem.5, 182–185 (2013).
- Balasubramanian S , HurleyLH, NeidleS. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?Nat. Rev. Drug Discov.10, 261–275 (2011).
- Shalaby T , FiaschettiG, NagasawaK, Shin-yaK, BaumgartnerM, GrotzerM. G-quadruplexes as potential therapeutic targets for embryonal tumors. Molecules18, 12500–12537 (2013).
- Tan JH , GuLQ, WuJY. Design of selective G-quadruplex ligands as potential anticancer agents. Mini Rev. Med. Chem.8, 1163–1178 (2008).
- Yang D , OkamotoK. Structural insights into G-quadruplexes: towards new anticancer drugs. Future Med. Chem.2, 619–646 (2010).
- Lemarteleur T , GomezD, PaterskiR, MandineE, MaillietP, RiouJ-F. Stabilization of the c-myc gene promoter quadruplex by specific ligands’ inhibitors of telomerase. Biochem. Biophys. Res. Comm.323, 802–808 (2004).
- Riou JF , GuittatL, MaillietPet al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc. Natl Acad. Sci. USA99, 2672–2677 (2002).
- Di Leva FS , NovellinoE, CavalliA, ParrinelloM, LimongelliV. Mechanistic insight into ligand binding to G-quadruplex DNA. Nucleic Acids Res.42, 5447–5455 (2014).
- Nagle PS , McKeeverC, RodriguezF, NguyenB, WilsonWD, RozasI. Unexpected DNA affinity and sequence selectivity through core rigidity in guanidinium-based minor-groove binders. J. Med. Chem.57, 4397–4406 (2014).
- Kim MY , DuanWH, Gleason-GuzmanM, HurleyLH. Design synthesis and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes. J. Med. Chem.46, 571–583 (2003).
- Monchaud D , Teulade-FichouM-P. A hitchhiker’s guide to G-quadruplex ligands. Org. Biomol. Chem.6, 627–636 (2008).
- Wheelhouse RT , SunDK, HanHY, HanFXG, HurleyJH. Cationic porphyrins as telomerase inhibitors: the interaction of tetra-(N-methyl-4-pyridyl)porphine with quadruplex DNA. J. Am. Chem. Soc.120, 3251–3262 (1998).
- Pratviel G . Porphyrins in complex with DNA: modes of interaction and oxidation reactions. Coord. Chem. Rev.308, 460–477 (2016).
- Senge MO . Exercises in molecular gymnastics – bending, stretching and twisting porphyrins. Chem. Commun. (3), 243–256 (2006).
- Senge MO , MacGowanSA, O’BrienJM. Conformational control of cofactors in nature – the influence of protein-induced macrocycle distortion on the biological function of tetrapyrroles. Chem. Commun.51, 17031–17063 (2015).
- Nicoludis JM , BarrettSP, MergnyJL, YatsunykLA. Interaction of human telomeric DNA with N-methyl mesoporphyrin IX. Nucleic Acids Res.40, 5432–5447 (2012).
- Nicoludis JM , MillerST, JeffreyPDet al. Optimized end-stacking provides specificity of N-methyl mesoporphyrin IX for human telomeric G-quadruplex DNA. J. Am. Chem. Soc.134, 20446–20456 (2012).
- Cai X , GrayPJJr, von HoffDD. DNA minor-groove binders: back in the groove. Cancer Treat. Rev.35, 437–450 (2009).